Evaluation of Educational Interventions Targeting Beliefs About Human Papillomavirus (HPV)
1 other identifier
interventional
102
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effects of two different educational training programs on beliefs about Human Papillomavirus (HPV) in a group of female hospital employees. The main questions it aims to answer are: • Within the scope of the study, are the training programs provided to reduce misconceptions about HPV effective? • Which educational program is more effective in reducing misconceptions about HPV? Participants will • Complete a pre-test online the day before the first training date to determine the level of their misconceptions about HPV. • Receive informative messages via Whatsapp once a day for three days according to the training program they are assigned to. • Repeat the pre-test at the end of the training programs and one month later. • Receive the more effective training program after one month after the test repetition for the control group. Researchers will compare "Misbeliefs about HPV" and "Current Knowledge about HPV" titled training programs on reducing misconceptions about HPV.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 25, 2023
CompletedFirst Posted
Study publicly available on registry
January 10, 2024
CompletedStudy Start
First participant enrolled
March 29, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedAugust 28, 2024
August 1, 2024
6 months
December 25, 2023
August 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health Beliefs about Human Papillomavirus (HPV)
Measuring with: "False Beliefs About HPV Scale"
From enrollment to the end of intervention at 4 weeks
Study Arms (2)
Training for HPV misbeliefs 1
EXPERIMENTALParticipants will receive misbeliefs about HPV; training where misbeliefs are mentioned before the current information.
Training for HPV misbeliefs 2
EXPERIMENTALParticipants will receive misbeliefs about HPV; training where misbeliefs are mentioned after the current information.
Interventions
Intervention trainings mentioned false beliefs before or after the current knowledge
Eligibility Criteria
You may qualify if:
- Woman
- Age \>18 years and older
- Those who agree to participate in the study
You may not qualify if:
- Age \<18 years
- Those who not agree to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Eskisehir Osmangazi University Public Health Department
Odunpazari, Eskişehir, 26040, Turkey (Türkiye)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
December 25, 2023
First Posted
January 10, 2024
Study Start
March 29, 2024
Primary Completion
October 1, 2024
Study Completion
December 1, 2024
Last Updated
August 28, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- As of March 2024
- Access Criteria
- "Access to trial IPD can be requested by qualified researchers engaging in independent scientific research and will be provided following review and approval of a research proposal and Statistical Analysis Plan (SAP) and execution of a Data Sharing Agreement (DSA). For more information or to submit a request, please contact selvadilangolbasi@gmail.com"
Data obtained through this study may be provided to qualified researchers with academic interest in beliefs about Human Papillomavirus. Data or samples shared will be coded, with no PHI included. Approval of the request and execution of all applicable agreements are prerequisites to the sharing of data with the requesting party.